Genomic alterations in blast phase of BCR::ABL1 ‐negative myeloproliferative neoplasms
International Journal of Laboratory Hematology · 2023
DOI: 10.1111/ijlh.14184 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Laboratory Hematology, 2023. Verfasst von Dong Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, UConn Health, Farmington, Connecticut, USA. Hauptthemen laut MEDLINE: Blast Crisis, Myeloproliferative Disorders. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
The blast phase of BCR::ABL1 ‐negative myeloproliferative neoplasm (MPN‐BP) represents the final stage of the disease, which is complicated by complex genomic alterations. These alterations result from sequence changes in genetic material (DNA, RNA) and can lead to either a gain or loss of function of encoded proteins, such as adaptor proteins, enzymes, components of spliceosomes, cell cycle checkpoints regulators, transcription factors, or proteins in cell signaling pathways. Interference at various levels, including transcription, translation, and post‐translational modification (such as methylation, dephosphorylation, or acetylation), can contribute to these alterations. Mutated genes such as ASXL1, EZH2, IDH1, IDH2, TET2, SRSF2, U2AF1, TP53, NRAS, KRAS, PTPN11, SH2B3/LNK , and RUNX1 play active roles at different stages of genetic material expression, modification, and protein function manipulation in MPNs. These mutations are also correlated with, and can contribute to, the progression of MPN‐BP. In this review, we summarize their common mutational profiles, functions, and associations with progression of MPN‐BP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, UConn Health, Farmington, Connecticut, USA.
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
ORCID-Profile: Dong Chen, Olga K Weinberg
Zitieren
APA
Chen, D., & Weinberg, O. K. (2023). Genomic alterations in blast phase of BCR::ABL1 ‐negative myeloproliferative neoplasms. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14184
Vancouver
Chen D, Weinberg OK. Genomic alterations in blast phase of BCR::ABL1 ‐negative myeloproliferative neoplasms. International Journal of Laboratory Hematology. 2023. doi:10.1111/ijlh.14184
BibTeX
@article{Chen2023,
author = {Chen, Dong and Weinberg, Olga K},
title = {Genomic alterations in blast phase of BCR::ABL1 ‐negative myeloproliferative neoplasms},
journal = {International Journal of Laboratory Hematology},
year = {2023},
doi = {10.1111/ijlh.14184}
}
EUVIMED